Translate Bio, Inc. (TBIO) [Rocket]

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	S-1/A
Revenues	138.8	7.8	1.4	0.0	15.7
Revenue growth	1678.7%	449.6%		-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	26.8
Gross profit	138.8	7.8	1.4	0.0	-11.1
Gross margin	100.0%	100.0%	100.0%		-71.2%
Selling, general and administrative [+]	35.9	28.6	22.6	14.3	11.1
General and administrative	35.9	28.6	22.6	14.3	11.1
Research and development	109.6	76.4	58.0	47.0
Other operating expenses	48.6	0.0	25.0	17.9	4.5
EBITDA [+]	-46.0	-92.5	-101.4	-77.7	-26.1
EBITDA growth	-50.2%	-8.8%	30.5%	197.9%
EBITDA margin	-33.2%	-1185.0%	-7140.1%		-166.5%
Depreciation and amortization	9.3	4.7	2.8	1.6	0.7
EBIT [+]	-55.3	-97.2	-104.2	-79.2	-26.8
EBIT growth	-43.1%	-6.7%	31.5%	195.7%
EBIT margin	-39.8%	-1245.6%	-7340.1%		-171.2%
Non-recurring items [+]		18.6
Asset impairment		18.6
Interest income			1.3	0.3	0.1
Interest income			1.3	0.3	0.1
Other income (expense), net [+]	1.5	2.0	-0.1	0.0	0.0
Change in value of contingent liability	48.6	0.0	25.0	17.9
Other	1.5	2.0	-0.1	0.0	0.0
Pre-tax income	-53.8	-113.8	-103.0	-78.9	-26.7
Income taxes	0.0	-0.5	-5.6	-12.5	0.0
Tax rate	0.0%	0.4%	5.4%	15.8%	0.0%
Net income	-53.8	-113.3	-98.0	-67.2	0.0
Net margin	-38.7%	-1451.7%	-6904.2%		-0.2%

Basic EPS [+]	($0.80)	($2.20)	($3.64)	($8.66)	($18.14)
Growth	-63.8%	-39.5%	-58.0%	-52.3%
Diluted EPS [+]	($0.80)	($2.20)	($3.64)	($8.66)	($18.14)
Growth	-63.8%	-39.5%	-58.0%	-52.3%

Shares outstanding (basic) [+]	67.5	51.4	26.9	7.8	0.0
Growth	31.2%	90.9%	247.4%	513878.3%
Shares outstanding (diluted) [+]	67.5	51.4	26.9	7.8	0.0
Growth	31.2%	90.9%	247.4%	513878.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.